Noonan Syndrome/Leukemia-associated Gain-of-function Mutations in SHP-2 Phosphatase (PTPN11) Enhance Cell Migration and Angiogenesis
Open Access
- 1 January 2009
- journal article
- Published by Elsevier BV
- Vol. 284 (2), 913-920
- https://doi.org/10.1074/jbc.m804129200
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Conditional Deletion of Shp2 in the Mammary Gland Leads to Impaired Lobulo-alveolar Outgrowth and Attenuated Stat5 ActivationPublished by Elsevier BV ,2006
- Protein tyrosine phosphatases: from genes, to function, to diseaseNature Reviews Molecular Cell Biology, 2006
- SHP-2 activates signaling of the nuclear factor of activated T cells to promote skeletal muscle growthThe Journal of cell biology, 2006
- An Shp2/SFK/Ras/Erk Signaling Pathway Controls Trophoblast Stem Cell SurvivalDevelopmental Cell, 2006
- Effects of a Leukemia-associated Gain-of-Function Mutation of SHP-2 Phosphatase on Interleukin-3 SignalingJournal of Biological Chemistry, 2006
- Diverse Biochemical Properties of Shp2 MutantsJournal of Biological Chemistry, 2005
- Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cellsBlood, 2005
- Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factorBlood, 2005
- Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous LeukemiaCancer Research, 2004
- Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolismProceedings of the National Academy of Sciences of the United States of America, 2004